SHL Telemedicine Ltd. Files Form 6-K with Press Release
Ticker: SHMLF · Form: 6-K · Filed: Sep 24, 2024 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Sep 24, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, press-release
TL;DR
SHL Telemedicine filed a 6-K on 9/24/24 with a press release attached, referencing an older S-8 filing.
AI Summary
On September 24, 2024, SHL Telemedicine Ltd. announced the issuance of a press release, furnished as Exhibit 99.1 to this Form 6-K. This filing is incorporated by reference into the company's Form S-8 registration statement filed on June 9, 2023.
Why It Matters
This filing indicates ongoing corporate communications and regulatory compliance for SHL Telemedicine Ltd., potentially impacting investor awareness of company activities.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain new financial or operational information that would immediately impact risk.
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- September 24, 2024 (date) — Date of press release issuance
- Exhibit 99.1 (document) — Press release attached to Form 6-K
- Form S-8 (document) — Registration statement referenced
- June 9, 2023 (date) — Date of Form S-8 filing
- 333-272546 (registration_number) — Registration number for Form S-8
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to furnish a press release, dated September 24, 2024, as Exhibit 99.1, and to note its incorporation by reference into a previously filed Form S-8 registration statement.
When was the press release mentioned in the filing issued?
The press release was issued on September 24, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Which registration statement is this Form 6-K incorporated into?
This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed on June 9, 2023 (Registration No. 333-272546).
Does this filing indicate the company files annual reports under Form 20-F or 40-F?
Yes, the filing indicates by check mark that the registrant files annual reports under Form 20-F.
Filing Stats: 201 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-09-24 07:53:04
Filing Documents
- zk2432065.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 5KB
- image00001.jpg (GRAPHIC) — 13KB
- 0001178913-24-003130.txt ( ) — 35KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On September 24, 2024, SHL Telemedicine Ltd. (the " Company ") issued a press release, a copy of which is furnished herewith as Exhibit 99.1. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546 ). Exhibit Description 99.1 Press release, dated September 24, 2024, issued by the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer September 24, 2024